ALP Bio

Schlieren, Switzerland

ALP AI is at the forefront of advancing immunogenicity intelligence for biologics.

$2.2M raised

Apr 2026

Pre-Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has ALP Bio raised?

ALP Bio has raised $2.2M in total funding. The most recent round was Pre-Seed. The last funding was announced in April 2026.

Who are ALP Bio's investors?

ALP Bio's investors include 42CAP, Venture Kick, Ajira Ventures.

Where is ALP Bio headquartered?

ALP Bio is headquartered in Schlieren, Switzerland.

What does ALP Bio do?

ALP AI is at the forefront of advancing immunogenicity intelligence for biologics.

What stage is ALP Bio at?

ALP Bio is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 30, 2026.

MLA

"ALP Bio — Funding & Investors." VCBacked, April 30, 2026, https://www.vcbacked.co/company/alp-bio. Accessed July 2, 2026.

APA

VCBacked. (2026). ALP Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/alp-bio

Wikipedia (cite web)

{{cite web |title=ALP Bio — Funding & Investors |url=https://www.vcbacked.co/company/alp-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 30, 2026.